Tag Archives: R&D

BudLife

Sugarmade Announces Details of BudLife Cannabis Storage Products

Sugarmade Announces Details of BudLife Cannabis Storage Products

INDUSTRY, Calif., Aug. 24, 2017 /Weed Wire/ — Sugarmade, Inc. (OTCQB:SGMD), today announces new details of its upcoming BudLife product line, the first patented, container system designed to maintain the integrity of cannabis during long-term storage. Sugarmade and its manufacturing partner, Plantation Corp., have been testing several prototype versions of BudLife over the past few months.

Puerto Rico Medical Cannabis Legalization Enacted by Governor

Puerto Rico Medical Cannabis Legalization Enacted by Governor

Puerto Rico medical cannabis legalization has become a legislative reality. On July 9, 2017, Puerto Rico Gov. Ricardo Rosselló Nevares signed the Law to Improve the Study, Development and Research of Cannabis for Innovation, Applicable Norms and Limits, also known as MEDICINAL Law, to regulate medical cannabis on the Caribbean island.

Governor Rosselló Nevares Signs the Medicinal Law for the Use of Medical Cannabis

LA FORTALEZA, P.R., July 9, 2017 /Weed Wire/ — Governor Ricardo Rosselló Nevares today signed the Law to Improve the Study, Development and Research of Cannabis for Innovation, Applicable Norms and Limits (MEDICINAL Law), which regulates the use of medicinal cannabis in Puerto Rico, in order to comply with one of the commitments contained in the Plan for Puerto Rico.

CURE Pharmaceutical

CURE Pharmaceutical and CannaKids Announces Research Collaboration with Technion Israel Institute of Technology on Cancer-Fighting Cannabinoids

OXNARD, Calif., May 31, 2017 /Weed Wire/ — CURE Pharmaceutical (OTCQB: CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that the company’s partnership with CannaKids has entered into a strategic research collaboration with Technion Research and Development Foundation Ltd., a wholly owned subsidiary of the Technion Israel Institute of Technology, in order to research how different cannabinoid compounds within cannabis strains can be used to treat various subtypes of cancer.

MJICM_iCAN-Trio-PR-Web

iCAN- Israel Cannabis and Breath of Life Pharma Announce Partnership in Israel’s First Private Cannabis R&D Incubator Center

TEL AVIV, Isarel, March 10, 2016 /Weed Wire/ — iCAN- Israel Cannabis and Breath of Life Pharma (BOL Pharma) announced a new partnership to form the first private cannabis R&D incubator center in Israel.


Top